When people learn that approximately 95% of the body's serotonin is produced in the gut rather than the brain, the reaction is usually disbelief. Serotonin is synonymous with mood and depression in popular health culture. The idea that it originates in the digestive tract — and that the bacteria living there are the upstream regulators — seems almost implausible until you understand the biology.
The gut produces serotonin through a class of cells called enterochromaffin cells, which line the intestinal wall. These cells synthesise serotonin in response to mechanical and chemical stimuli — including, critically, the metabolic byproducts produced by gut bacteria. The bacteria are not incidental to this process. Evidence now suggests they are central to it.
The Bacterial Species That Drive Serotonin Production
Research published in Cell identified that spore-forming bacteria from the Clostridia class are the primary drivers of peripheral serotonin biosynthesis in the gut. These bacteria produce short-chain fatty acids — particularly butyrate — that directly stimulate enterochromaffin cells to produce serotonin. Individuals with gut microbiomes enriched in butyrate-producing species tend to produce more peripheral serotonin than those whose microbiomes are deficient in these bacteria.
In the GutType framework, Type A Cultivators typically have the microbial profile most conducive to serotonin production — high diversity, abundant butyrate producers, and the fermentation capacity to generate the substrates that drive enterochromaffin cell activity. Type B Sentinels, whose microbiomes are often characterised by dysbiosis and inflammation, may have suppressed serotonin production as a secondary effect of inflammatory signalling.
Studies in germ-free mice — animals raised without any gut microbiome — show dramatically reduced serotonin levels in the colon and blood compared to conventional mice. When gut bacteria from specific donor profiles were introduced, serotonin levels recovered in a species-dependent manner, demonstrating that bacterial composition directly determines serotonin output.
Beyond Serotonin: GABA, Dopamine, and the Enteric Nervous System
Serotonin is the most studied gut-derived neurotransmitter, but it is not the only one. Certain Lactobacillus and Bifidobacterium species produce GABA — the brain's primary inhibitory neurotransmitter, associated with calm, stress resilience, and focused attention. Research in Nature Microbiology found that Lactobacillus rhamnosus supplementation reduced anxiety-related behaviour and altered GABA receptor expression in mouse models — an effect that disappeared when the vagus nerve was severed, confirming the gut-brain pathway.
The enteric nervous system — the 500 million neurons embedded in the gut wall — functions as a semi-autonomous nervous system in continuous communication with the brain via the vagus nerve. Gut bacteria influence this signalling network directly, releasing neuroactive compounds that modulate emotional tone, stress reactivity, and cognitive function in ways that are now supported by multiple clinical studies.
The clinical evidence increasingly suggests that some cases of persistent low mood, anxiety, and brain fog are gut dysbiosis problems that present as mental health problems. The distinction matters because the intervention is different.
When the Factory Underperforms
Persistent fatigue, low mood, difficulty concentrating, and anxiety that do not respond to sleep, exercise, or stress management are frequently attributed to purely psychological causes. In a meaningful subset of cases, they may be the downstream neurological effects of gut microbial imbalance — insufficient production of serotonin precursors, reduced GABA synthesis, or elevated inflammatory cytokines that directly suppress neurotransmitter function.
This does not mean psychological causes are irrelevant, or that gut health is a universal cure for mental health conditions. It means that for some individuals, addressing the gut microbiome first may produce improvements in mood and cognition that years of other interventions did not — because the root cause was in the gut, not in thought patterns or lifestyle alone.
What Changes With the Right Protocol
The intervention is type-specific. Type D Adaptors, whose context-sensitive microbiomes respond quickly to targeted changes, often experience the most rapid mood improvements from microbiome-focused protocols. Type B Sentinels typically need inflammation reduction as a prerequisite — high inflammatory activity appears to suppress the neurotransmitter-producing bacteria regardless of what else is done.
Multiple randomised controlled trials have demonstrated that specific probiotic supplementation improves scores on validated anxiety and depression scales in healthy adults. The effective strains differ, and the appropriate choice depends on which species are deficient — which is a function of individual microbiome profile, not a one-size-fits-all recommendation.
Find your Gut Type and understand which specific imbalances may be affecting how you think and feel.
Sources & Further Reading
- Yano, J.M., et al. (2015). Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis. Cell, 161(2), 264–276.
- Bravo, J.A., et al. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences, 108(38), 16050–16055.
- Cryan, J.F., et al. (2019). The Microbiota-Gut-Brain Axis. Physiological Reviews, 99(4), 1877–2013.
- Valles-Colomer, M., et al. (2019). The neuroactive potential of the human gut microbiota in quality of life and depression. Nature Microbiology, 4, 623–632.
- Dinan, T.G., Stanton, C., & Cryan, J.F. (2013). Psychobiotics: a novel class of psychotropic. Biological Psychiatry, 74(10), 720–726.
